Effect of Post-operative Chlorhexidine on Postoperative Pain and Complications After Surgical Removal of Mandibular Third Molars
Launched by ISALA · Mar 17, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • healthy adults (18+) referred by their dentist for third molar removal
- Exclusion Criteria:
- • active pericoronitis or other infections
- • planned coronectomy
- • trismus
- • chronic pain
- • pregnancy
- • known allergies to local anesthesia
About Isala
Isala is a leading healthcare organization based in the Netherlands, renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a strong focus on collaboration and multidisciplinary approaches, Isala integrates clinical expertise and cutting-edge technology to develop and evaluate new treatments across various therapeutic areas. The organization prioritizes patient safety and ethical standards, ensuring that all research initiatives are conducted with the highest level of integrity. Through its dedication to scientific excellence and patient outcomes, Isala strives to contribute significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zwolle, Overijssel, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported